The CC utilizes three software tools-integrated relaxation pressure (IRP), distal contractile integral (DCI), and distal latency (DL)-to characterize motor function at the esophagogastric junction and the esophageal body. While CC version 3.0 simplified the classification of esophageal motor disorders, several motor abnormalities shifted out of the classification into the 'normal' category with this update. 7 For instance, rapid contractions (contraction velocity >8 cm/s) and hypertensive contractions (DCI >5000 mm Hg/cm/s) were replaced by premature contractions (DL <4.5 seconds) and hypercontractile peristalsis (DCI >8000 mm Hg/cm/s). New motor designations, such as ineffective esophageal motility (IEM) and fragmented peristalsis, were introduced. The impact of this changing landscape of esophageal motor disorders on motor diagnosis and symptom burden are unclear. Furthermore, contraction wave abnormalities (CWA), including multiple peaked waves, prolonged wave duration, simultaneous contractions (SC), and exaggerated contraction amplitudes, may not be identified by the averaging process incorporated into these software tools within the CC. 8, 9 In this study, we assessed the impact of CC versions 2.0 and 3.0 on the proportions of motor diagnoses made in clinical esophageal HRM studies. Furthermore, we assessed the impact of the averaging process of motor data during analysis of esophageal HRM, by determining the proportions of CWA that do and do not result in abnormal CC designations on versions 2.0 and 3.0. Finally, we compared symptom burden in patients with and without abnormal CC designations on versions 2.0 and 3.0.
| METHODS

| Subjects
This retrospective cohort study evaluated consecutive HRM studies performed over a 6-year period (2006) (2007) (2008) (2009) (2010) (2011) 
| Esophageal HRM
All patients were studied after an overnight fast and after discontinuing medications that can affect esophageal motor function (metoclopramide, anticholinergic medication, smooth muscle relaxants) for 5-7 days prior to the study, as previously described. 8 Briefly, a solid-state HRM catheter assembly (36 solid-state sensors spaced at 1-cm intervals, 4.2 mm diameter) was placed transnasally after topical anesthesia to the nasal passages. Studies were performed with the patient supine and slightly tilted to the left for ease of swallowing. A 20-second swallow-free period (landmark phase) was obtained after the patient was settled and resting quietly. Esophageal peristaltic function was assessed with 10 wet swallows of 5 mL ambient temperature water, administered ≥20 seconds apart. Pressure data were acquired using dedicated HRM software (Manoview, Given Imaging/ Covidien/Medtronic).
| Analysis of HRM data
The esophageal HRM studies were first interpreted clinically using Contraction wave abnormalities were identified in the esophageal body as follows [9] [10] [11] : (i) averaged esophageal body contraction amplitudes ≥180 mm Hg in the distal esophagus (NE), (ii) >20% SC, identified by contraction front velocity >6.8 cm/s, (iii) any multiple
Key Points
• High-resolution manometry (HRM) algorithms for interrogation of esophageal motor phenomena vary between Chicago Classification (CC) versions 2.0 and 3.0. We evaluated 2569 HRM studies using both CC 2.0 and 3.0 criteria.
• CC 3.0 criteria are less sensitive, but identify motor disorders with highest symptom burden compared to CC 2.0.
• A 'normal' designation on both CC 2.0 and 3.0 remains compatible with contraction wave abnormalities (CWA), which are associated with a higher likelihood of esophageal symptoms compared to true normal studies. 
| Symptom assessment
Whenever possible, patients presenting for esophageal HRM at our center are asked to complete symptom questionnaires. In these questionnaires, patients self-report their dominant and secondary symptom frequency and severity, as well as a global esophageal symptom assessment. 12, 13 The frequency and severity for each symptom are rated on 5-point Likert scales generated a priori for esophageal physiologic studies at our institution, utilized in prior publications, and validated for assessment of esophageal symptoms in both esophageal motor disorders and gastroesophageal reflux dis- 
| Statistical methods
Data are reported as mean±SEM unless otherwise noted. Proportions of cohorts with and without CC 2.0 and 3.0 designations and their motor patterns were determined and compared using the chi-squared test for categorical data. Demographics (age and gender) and symptom burden metrics (DSI and GSS) were compared between and within cohorts and motor patterns meeting CC 2.0 and 3.0 criteria, CWA, and true normal HRM studies, using Student's t-test or ANOVA, as appropriate, for continuous data. All analyses were two-tailed and P<.05 was required for statistical significance. Analyses were performed using IBM SPSS Statistics V.22.0 (Armonk, NY, USA).
| RESULTS
| Study cohort
The 6-year study period yielded a total of 2634 patients undergoing HRM studies. Of these, 65 (2.5%) were incomplete or critically imperfect and were excluded from further analysis ( Figure 2 ). The remaining 2569 patients (54.6±0.3 years, 63.5% female) fulfilled study inclusion criteria, and represented the study cohort. Based on available symptom questionnaire data, the study cohort had moderate-to-severe symptom burden, with DSI of 10.4±0.1 (out of 16) and GSS of 6.0±0.1 (out of 10). The most frequent presenting symptoms were heartburn (23.7%) and dysphagia (16.8%).
| CC 2.0 and 3.0 diagnoses
With both CC 2.0 and 3.0, hypermotility disorders were the least common diagnosis made, while the majority-more than half the studies-did not fulfill criteria for a CC motor diagnosis (Figure 2 ). There was a sig- 
| Discordance between CC 2.0 and 3.0
Taking all motor diagnoses including lack of a CC diagnosis into consideration, CC 2.0 and 3.0 diagnoses were concordant in 82.8%, while 17.2% of diagnoses were discordant ( Figure 3 ). There were 333 pa- 
| Contraction wave abnormalities
Of the study cohort, 884 patients (34.4%, 57.7±0.5 years, 67.1% female) were identified with CWA, of which 472 (53.4%) and 329
(37.2%) met CC 2.0 and 3.0 criteria for a motor diagnosis, respectively.
When compared to patients with a "normal" study (no CC 2.0 and 3.0 diagnoses), patients with CWA but without a CC diagnosis had higher proportions of presenting symptoms of dysphagia, heartburn, and regurgitation ( Figure 4A and B, P≤.01 for all comparisons). The proportions of patients meeting CC 2.0 and 3.0 diagnoses were higher for those presenting with dysphagia (66.5% and 52.4%, respectively) compared to patients with other symptoms (P<.001 for both comparisons).
In the setting of dysphagia, patients with criteria for both CWA and a CC diagnosis were most prevalent, followed by those with CWA but Within the CWA cohorts, the presence of criteria for CC 2.0 and 3.0 diagnoses were highest for 'NE' (89.4% and 67.3%, respectively) and SC (76.1% and 54.0%, respectively); prevalence was lowest for DPW (39.7% and 27.8%, respectively; Table 2 ). The proportions of patients meeting CC 2.0 for each CWA designation were higher than those meeting CC 3.0 (P≤.045).
F I G U R E 2 Schematic flow diagram of study design. Although similar proportions of outflow obstruction were found on CC 2.0 and 3.0, there were lower proportions of HRM studies meeting hypermotility and hypomotility diagnostic criteria on CC 3.0 compared to CC 2.0. Consequently, proportions designated 'normal' were higher with CC 3.0
| DISCUSSION
In this report evaluating over 2500 esophageal motility studies using both CC 2.0 and 3.0, we demonstrate that the CC 3.0 classification is more selective than CC 2.0, with significantly fewer patients meeting CC 3.0 criteria compared to CC 2.0. While the proportions with esophageal outflow obstruction are similar, the attrition of motor diagnoses with CC 3.0 is primarily from excluding patients meeting CC 2.0 hypermotility and hypomotility disorders based upon changes in the definitions of motor disorders within these categories. Furthermore, our data demonstrate CC 3.0 selects patients with higher symptom burden, in contrast to CC 2.0, where symptom burden metrics were similar between patients meeting and not meeting criteria for a motor diagnosis. Finally, we demonstrate that certain CWA do not fulfill criteria for a CC diagnosis, especially with CC 3.0.
Despite this, within these 'normal cohorts' not meeting CC criteria, more symptomatic patients have CWA than a truly normal study.
These differences were most striking for dysphagia as a presenting symptom, and suggest the importance of inspecting the motility study and potentially recording the presence of CWA in addition to making a CC diagnosis.
For this study, we have grouped esophageal body motor disorders by pathophysiologic designation, rather than by their original CC characterization into major and minor motor disorders. We have previously demonstrated that pathophysiologic designation into esophageal outflow obstruction, hypermotility, and hypomotility disorders facilitates comparison of symptom burden between disorders, and better representation of symptoms. 9 Specifically, absent contractility aligns better with the two CC 3.0 minor disorders (IEM and fragmented peristalsis) in that reflux burden is higher with these hypomotility disorders, while dysphagia prevalence is lower compared to the major disorders (hypercontractile disorder and DES). Furthermore, this grouping was necessary to compare motor disorders across the two classification systems.
With the transition from CC 2.0 to 3.0, several key modifications contributed to new diagnostic designations in the CC 3.0 criteria. Therefore, as many as 17.2% of motor diagnoses changed between CC 2.0 and 3.0, mostly from a loss of hypermotility (4.4%) and hypomotility (9.0%) designations, resulting in a gain in the 'no CC diagnosis' category of 13.0% in CC 3.0 (Figure 3) . T A B L E 1 Symptom burden by motor patterns for CC 2.0 and 3.0 diagnoses
Our data suggest that a 'normal' study according to either version of CC does not preclude abnormalities in the peristaltic wave, lumped together and termed CWA for this study. Supporting the existing data available from prior reports in the literature, our data suggest that CWA may be clinically relevant, especially when dysphagia is a presenting symptom. In past studies evaluating patients with non-obstructive dysphagia, CWA, especially SC, were more evident compared to normal volunteers, both with routine conventional manometry and with provocative studies using esophageal air or fluid infusion. 15, 16 Simultaneous (or rapid) peristalsis has been reported to have similar implications as DES according to CC 3.0, 17 with significant dysphagia rates regardless of whether CC 3.0 criteria were fulfilled. Simultaneous and retrograde contractions have been induced by balloon distension studies, both using conventional manometry where typical symptoms were reproduced with balloon distension, 18 and more recently, using the functional luminal imaging probe and evaluating esophageal luminal diameter changes in response to balloon distension. 19 In some symptomatic patients, limited data suggest that asynchrony between esophageal circular and longitudinal muscle contraction can potentially explain bolus transit abnormalities. 20 Therefore, CWA could potentially increase the suspicion for obstructive esophageal pathophysiology in the setting of dysphagia, 21 and lead the clinician toward further evaluation for obstruction, or empiric dilation.
Alternatively, increased esophageal sensitivity and hypervigilance are also reported in conjunction with CWA, especially in the setting of perceptive symptoms like heartburn and chest pain. 26 These data suggest that CWA could represent a minor motor disorder which may not be pathognomonic for a defined motor diagnosis, but one which can potentially explain esophageal symptoms, particularly transit symptoms like dysphagia. Therefore, we believe it is important to recognize abnormalities in the contraction wave before designating a motility study as normal, using either of CC 2.0 and 3.0. The clinical utility of identification of CWA in these settings is that this could lead to further evaluation for a subtle structural or motor explanation for dysphagia, or treatment for hypervigilance, in contrast to a completely normal manometry devoid of CWA, where the manometry study does not explain the symptomatic presentation.
This study has limitations inherent to its retrospective cohort study design. Processes such as gastroesophageal reflux or functional esophageal syndromes may have contributed to symptom burden in these patients, but were not uniformly assessed in this study.
Outcome data from therapy arising from the motor assessments would have added further value to our analysis, but were not available.
There remains the possibility of referral bias to our tertiary referral academic center, potentially limiting the generalizability of our findings.
Outcome data would have further enhanced our report, which was not available in this patient cohort. Finally, results from provocative testing (multiple rapid swallows) were not utilized to further evaluate or characterize CWA in this report, since data collection predated routine use of provocative testing in our institution. Nonetheless, on the strength of its large sample size, our study offers valuable information that CC 3.0 is more specific compared to CC 2.0, and that CWA are clinically relevant and deserve recognition in reporting of esophageal motor function. Our findings could lead to further prospective studies evaluating the relationship between esophageal motor patterns and symptom burden.
In conclusion, we demonstrate that 82.8% of motor diagnoses are generally concordant between CC 2.0 and 3.0. CC 3.0 identifies the more extreme motor disorders with higher symptom burden, and is more specific within the diagnoses made when compared to its predecessor CC 2.0. The averaging process used with CC software tools pertaining to the esophageal body results in the lack of designation of several motor patterns (CWA), previously identified in relationship with esophageal symptoms. These motor patterns can be associated with esophageal symptoms, and could represent an additional minor disorder of esophageal body peristalsis.
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